In this inaugural episode, experts discuss the limitations of current diagnosis-based frameworks in suicide research, emphasizing the need for more targeted interventions.
Psychopharm Today
In the first ever episode of "Psychopharm Today," experts unpack why suicide needs its own research, how to design targeted studies, and what clinicians can do beyond diagnosis to reduce risk.
Advertisement
Advertisement
Advertisement
Trending on Psychiatric Times
1
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
2
“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media
3
Monoamines: A Full House
4
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
5